Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

32 ta ish

Ish: Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan—A Retrospective Cohort Study

  1. Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

    Helen Cox, Stobdan Kalon, Sholpan Allamuratova +6

    Maqola200712 iqtibos
    ABI

  2. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    MaqolaTuberculosis Research and EpidemiologyNew England Journal of Medicine20226 iqtibos
    ABI

  3. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

    Sharh maqola20204 iqtibos
    ABI

  4. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

    Parvati Nair, T. Hasan, K. K. Zaw +9

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20224 iqtibos
    ABI

  5. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

    Maqola20123 iqtibos
    ABI

  6. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  7. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  8. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

    S. Moe, M. L. Rekart, D. Hernandez +9

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20232 iqtibos
    ABI

  9. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  10. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  11. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan

    S. Moe, I. Azamat, Sholpan Allamuratova +14

    MaqolaTuberculosis Research and EpidemiologyIJTLD OPEN20241 iqtibos
    ABI

  12. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

    Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

    MaqolaTuberculosis Research and EpidemiologyClinical Infectious Diseases20251 iqtibos
    ABI

  13. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI